Cognizant shares jump as investors appear to lean into stronger 2026 outlook

Cognizant Technology Solutions (CTSH) is up 6.8% today. Here is some analysis on what might have caused this price movement. ([cognizant.com](https://www.cognizant.com/en_us/about/documents/cognizant-q1-2026-corporate-overview.pdf?utm_source=openai))

Analysis: A single same-day catalyst is not obvious, so the move appears tied to improving sentiment around Cognizant’s stronger 2026 outlook, margin expansion targets, and AI-related growth positioning. This could also be because investors are responding to a series of higher analyst price targets that followed the company’s late-July results. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1058290/000105829026000030/exhibit9936302026.htm?utm_source=openai))

Details:

Cognizant’s July 29 earnings materials showed second-quarter revenue of about $5.48 billion, with full-year 2026 revenue guidance of roughly $22.04 billion to $22.35 billion and adjusted diluted EPS guidance of $5.70 to $5.82. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1058290/000105829026000030/exhibit9936302026.htm?utm_source=openai))

The same guidance package pointed to adjusted operating margin of 16.0% to 16.2%, implying year-over-year expansion, which can support a more constructive view on execution and profitability. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1058290/000105829026000030/exhibit9936302026.htm?utm_source=openai))

Recent analyst sentiment has been firmer after earnings, with multiple price-target increases recorded in late July and early September. ([tipranks.com](https://www.tipranks.com/stocks/ctsh/forecast?utm_source=openai))

Recent company announcements have also emphasized AI hiring, workforce development, and enterprise AI services, reinforcing the longer-term growth narrative around the business. ([news.cognizant.com](https://news.cognizant.com/2026-09-07-Cognizant-Invests-in-Americas-AI-Era-Workforce?utm_source=openai))

Sources:

Cognizant, SEC, TipRanks

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CTSH Insider Trading Activity

$CTSH insiders have traded $CTSH stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $CTSH stock by insiders over the last 6 months:

JATIN P DALAL (Chief Financial Officer) sold 12,000 shares for an estimated $669,168
JOHN SUNSHIN KIM (CLO, CAO & Corporate Secretary) has made 0 purchases and 2 sales selling 5,000 shares for an estimated $301,055.
ALINA KERDMAN (SVP, Controller & CAO) has made 0 purchases and 7 sales selling 1,039 shares for an estimated $56,938.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$CTSH Hedge Fund Activity

We have seen 453 institutional investors add shares of $CTSH stock to their portfolio, and 686 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 14,952,942 shares (+inf%) to their portfolio in Q2 2026, for an estimated $579,127,443
GQG PARTNERS LLC removed 8,116,278 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $497,933,655
SG AMERICAS SECURITIES, LLC added 6,957,414 shares (+4285.9%) to their portfolio in Q2 2026, for an estimated $269,460,644
PZENA INVESTMENT MANAGEMENT LLC added 6,266,810 shares (+30.9%) to their portfolio in Q2 2026, for an estimated $242,713,551
WELLINGTON MANAGEMENT GROUP LLP removed 4,639,888 shares (-95.6%) from their portfolio in Q2 2026, for an estimated $179,702,862
MORGAN STANLEY removed 4,323,996 shares (-32.6%) from their portfolio in Q2 2026, for an estimated $167,468,365
MILLENNIUM MANAGEMENT LLC added 3,925,570 shares (+851.3%) to their portfolio in Q2 2026, for an estimated $152,037,326

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CTSH Congressional Stock Trading

Members of Congress have traded $CTSH stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CTSH stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 04/14.
SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.
REPRESENTATIVE KEVIN HERN sold up to $50,000 on 03/17.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$CTSH Analyst Ratings

Wall Street analysts have issued reports on $CTSH in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Susquehanna issued a "Positive" rating on 05/01/2026
Guggenheim issued a "Buy" rating on 04/30/2026
Wells Fargo issued a "Overweight" rating on 04/30/2026

To track analyst ratings and price targets for $CTSH, check out Quiver Quantitative's $CTSH forecast page.

$CTSH Price Targets

Multiple analysts have issued price targets for $CTSH recently. We have seen 12 analysts offer price targets for $CTSH in the last 6 months, with a median target of $69.0.

Here are some recent targets:

Bryan Bergin from TD Cowen set a target price of $47.0 on 06/26/2026
James Faucette from Morgan Stanley set a target price of $44.0 on 06/23/2026
Bryan Keane from Citigroup set a target price of $55.0 on 06/09/2026
Steven Wahrhaftig from Wedbush set a target price of $70.0 on 06/08/2026
Arvind Ramnani from Truist Securities set a target price of $66.0 on 06/01/2026
Dan Dolev from Mizuho set a target price of $68.0 on 05/06/2026
James Friedman from Susquehanna set a target price of $88.0 on 05/01/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.